New study data back HeartWare's HVAD, but stroke data worrying
This article was originally published in Clinica
Executive Summary
Further clinical trial data have backed the use of the HeartWare left ventricular assist device, developed by HeartWare International (Framingham, Massachusetts). The product, also called the HVAD, is a pump designed to be implanted next to the heart to aid patients with advanced heart failure who are awaiting a heart transplant.